Murcko scaffold
Ring system with 3 rings and 16 atoms
38 chemicals on CompoundList share this ring system.
- Rings
- 3
- Scaffold atoms
- 16
- Chemicals
- 38
- With full pages
- 5
Scaffold SMILES
c1nc(NC2CCCCC2)c2cc[nH]c2n1
A Bemis-Murcko scaffold is what remains of a molecule when every side chain is removed: the rings and the chains that link them. Chemicals that share a scaffold often belong to the same compound series, which helps when you look for analogues, alternative suppliers or related building blocks.
Computed from the structures of the chemicals listed here. Stereo and charges are removed before the scaffold is taken.
Chemicals with this scaffold
Open one to see its structure, properties and suppliers.
Showing 1 to 38 of 38 chemicals
N-Cyclohexyl-7-[3-(dimethylamino)propyl]-5,6-dimethylpyrrolo[2,3-d]pyrimidin-4-amine
CAS 902314-35-6C19H31N5
N-Cyclohexyl-2-methylsulfanyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine
CAS 54532-52-4C13H18N4S
N-Cyclohexyl-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine
CAS 252722-30-8C13H18N4
N-Allyl-N-cyclohexyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine
CAS 252853-16-0C15H20N4
N-Methyl-N-(2-methylcyclohexyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine
CAS 252853-84-2C14H20N4
N-Methyl-N-(4-methylcyclohexyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine
CAS 252853-23-9C14H20N4
N-Methyl-N-(3-methylcyclohexyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine
CAS 252853-22-8C14H20N4
Oclacitinib maleate
CAS 1208319-27-0C19H27N5O6S
Oclacitinib
CAS 1208319-26-9C15H23N5O2S
N-(2,5-Dimethylcyclohexyl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine
CAS 252853-57-9C15H22N4
N-(2-Ethylcyclohexyl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine
CAS 252853-85-3C15H22N4
N-(2,2-Dimethylcyclohexyl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine
CAS 252853-60-4C15H22N4
N-(2-Methoxycyclohexyl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine
CAS 1259403-99-0C14H20N4O
trans-N,N-Dimethyl-4-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)cyclohexanemethanesulfonamide
CAS 1312034-35-7C16H25N5O2S
N-(3,4-Dimethylcyclohexyl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine
CAS 252853-58-0C15H22N4
N-(3,5-Dimethylcyclohexyl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine
CAS 252853-44-4C15H22N4
Cyclohexyl-methyl-(6-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amine
CAS 252722-85-3C14H20N4
Apoquel
CAS 1640292-55-2C19H27N5O6S
Oclacitinib impurity 44
CAS 1208319-33-8C14H20N4O
Abrocitinib impurity 56
CAS 1208319-36-1C16H25N5O2S
Oclacitinibmaleate
C19H27N5O6S
N-(4-Ethylcyclohexyl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine
CAS 252853-66-0C15H22N4
N-(2,4-Dimethylcyclohexyl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine
CAS 252853-87-5C15H22N4
N-(3,3-Dimethylcyclohexyl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine
CAS 252853-78-4C15H22N4
- 2-Chloro-N-cyclohexyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine1922972-47-1C12H15ClN4
- (Trans-4-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)cyclohexyl)methanesulfonic acid2124221-13-0C14H20N4O3S
- 1 supplierstrans-N1-Methyl-N1-7H-pyrrolo[2,3-d]pyrimidin-4-yl-1,4-cyclohexanediamine2612339-47-4C13H19N5
- (1r,4r)-N1,N1-dimethyl-N4-{7H-pyrrolo[2,3-d]pyrimidin-4-yl}cyclohexane-1,4-diamine2196204-97-2C14H21N5
- Potassium (trans-4-(methyl-(7H-pyrrolo(2,3-d)pyrimidin-4-yl)-amino)-cyclohexyl)-methanesulfonate2124221-14-1C14H19KN4O3S
- Lirucitinib2458115-78-9C16H25N5OS
- Sodium (trans-4-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)cyclohexyl)methanesulfonate2124221-17-4C14H19N4NaO3S
- Oclacitinib-13C-d32750534-84-8C15H23N5O2S
- 1-(Cyanomethyl)-3-((1r,4r)-4-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)cyclohexyl)urea2612339-52-1C16H21N7O
- 1-(4-(Methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)cyclohexyl)-3-(2,2,2-trifluoroethyl)urea2612339-53-2C16H21F3N6O
- Lirucitinib [INN]C16H25N5OS
- 2-(Cyclohexyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)ethanol1348319-01-6C14H20N4O
- N-Cyclohexyl-N-ethyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine252853-18-2C14H20N4
- N-Methyl-1-[4-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclohexyl]methanesulfonamide1538596-97-2C30H46N10O4S2